Good news for GlaxoSmithKline, and those U.K. parents wanting to get their hands on its meningitis B vaccine, Bexsero: The wait is over. Glaxo will have a global shortage resolved by next month, it ...

Bexsero (meningococcal group B vaccine) is a brand-name intramuscular injection. It’s prescribed to help prevent meningitis B. Bexsero has interactions with some other drugs. Examples include certain ...

Basel, July 29, 2014 - Novartis has announced the initial results of a large-scale vaccination campaign with Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) to help protect ...

The Advisory Committee on Immunization Practices (ACIP) recommendations have been updated for the meningococcal serogroup B MenB-4C vaccine (Bexsero), in accordance with the updated U.S. Food and Drug ...

The Breakthrough Therapy designation from the FDA will expedite the development and review of Bexsero. Novartis also plans to file for FDA approval by the second quarter of 2014. We note that Bexsero ...

GlaxoSmithKline is bringing its mom squad back to primetime. The “Moms Against Meningitis B” spot, a promo for GSK's vaccine Bexsero, is back on TV this month just in time for back-to-college, albeit ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved the recombinant vaccine, Bexsero, for prevention of Neisseria meningitidis serogroup B ...

Vaccine recommended to help protect persons over 10 years old in the United States (US) against disease-causing serogroups of Neisseria meningitidis (A, B, C, W, and Y) Broad serogroup coverage in one ...

Please provide your email address to receive an email when new articles are posted on . Recent findings in a phase 2b trial showed that a booster dose for the three-dose serogroup B meningococcal ...

With today`s approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide Bexsero`s two-dose regimen offers a flexible dosing ...

Most Australian parents will be unable to buy a vaccine for the B strain of the dangerous meningococcal disease until the new year. Pharmaceutical company GlaxoSmithKline said increasing global demand ...

The Food and Drug Administration recently approved Novartis’ meningitis B vaccine, Bexsero, which had been used to vaccinate University students. The vaccine is now approved for use in 10- to ...